Michael Kurman currently serves as the President at Michael Kurman Consulting. He has spent over forty years in the oncology drug development field. He practiced community oncology in New Jersey where he participated as an investigator in NCI cooperative group clinical trials. During his career in the pharmaceutical industry, he has held positions of progressive responsibility at large-pharma, emerging-pharma and CRO companies. He consulting practice revolves around advising companies in the areas of strategic drug development, regulatory strategy, clinical trial design and analysis and competitive analysis.